{"id":8256,"date":"2024-01-24T04:19:20","date_gmt":"2024-01-23T22:49:20","guid":{"rendered":"https:\/\/indianpharmanetwork.co.in\/medicines\/?post_type=product&#038;p=8256"},"modified":"2026-01-29T09:50:15","modified_gmt":"2026-01-29T04:20:15","slug":"qinlock-price-india","status":"publish","type":"product","link":"https:\/\/indianpharmanetwork.co.in\/medicines\/product\/qinlock-price-india\/","title":{"rendered":"QINLOCK (ripretinib) tablets"},"content":{"rendered":"<h4>Qinlock is a cancer medicine used\u00a0<b>to treat gastrointestinal stromal tumour (GIST), a cancer of the stomach and bowel.<\/b><\/h4>\n<p>Ripretinib, sold under the brand name Qinlock, is a medication for the treatment of adults with advanced gastrointestinal stromal tumor (GIST), a type of tumor that originates in the gastrointestinal tract. It is taken by mouth. Ripretinib is a kinase inhibitor, meaning it works by blocking a type of enzyme called a kinase, which helps keep the cancer cells from growing.<\/p>\n<p>Ripretinib was approved for medical use in the United States in May 2020, and in Australia in July 2020. Ripretinib is the first new drug specifically approved in the United States as a fourth-line treatment for advanced gastrointestinal stromal tumor (GIST).<\/p>\n<h4>Contact IPN \u2013 QINLOCK Access in India<\/h4>\n<p><strong>For inquiries regarding availability, import process, or cost of QINLOCK (ripretinib) :<\/strong><br \/>\n<strong>India Pharma Network (IPN)<\/strong>\u00a0: Headquartered in\u00a0<strong>New Delhi<\/strong>, with branch offices in\u00a0<strong>Delhi, Gurugram, Mumbai, Bangalore, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur\u00a0<\/strong>and<strong>\u00a0Lucknow<\/strong>, IPN supports medicine imports across India on a\u00a0<strong>Named Patient Import Basis<\/strong>\u00a0and for\u00a0<strong>personal use only<\/strong>.\u00a0<strong>Mobile\/WhatsApp:<\/strong>\u00a0Mr. Tarun: +91 9891 296 838 | \u00a0Mr. Neeraj: +91 9811 747 774.<strong>\u00a0Email:<\/strong>\u00a0<a href=\"mailto:info@indianpharmanetwork.co.in\" target=\"_blank\" rel=\"noopener\">info@indianpharmanetwork.co.in<\/a><\/p>\n<p><strong>NEWS \/ UPDATES<\/strong><\/p>\n<ul>\n<li>For QINLOCK (ripretinib)Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions\u00a0<a class=\"text-decoration-none\" href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/213973s000lbl.pdf\" target=\"_blank\" rel=\"noopener\">For More Details\u00a0<i class=\"fa fa-angle-double-right\"><\/i><\/a><\/li>\n<li>Genetics and Genomics of Gastrointestinal Stromal Tumors\u00a0<a class=\"text-decoration-none\" href=\"https:\/\/trigger.curetoday.com\/view\/educated-patient-gastrointestinal-stromal-tumor-webinar-janurary-26-2021\" target=\"_blank\" rel=\"noopener\">For More Details\u00a0<i class=\"fa fa-angle-double-right\"><\/i><\/a><\/li>\n<li>Deciphera (DCPH) Expert Survey is Positive on Qinlock Despite Selloff, Piper Sandler Reiterates Overweight\u00a0<a class=\"text-decoration-none\" href=\"https:\/\/www.streetinsider.com\/Analyst+Comments\/Deciphera+%28DCPH%29+Expert+Survey+is+Positive+on+Qinlock+Despite+Selloff%2C+Piper+Sandler+Reiterates+Overweight\/17914777.html\" target=\"_blank\" rel=\"noopener\">For More Details\u00a0<i class=\"fa fa-angle-double-right\"><\/i><\/a><\/li>\n<\/ul>\n<h5>Compliance &amp; Disclaimer<\/h5>\n<p>India Pharma Network acts solely as a facilitator for QINLOCK (ripretinib) access. IPN does not manufacture, sell, or promote medicines and does not provide medical advice. All imports are:<\/p>\n<ul>\n<li>Strictly on a Named Patient Import Basis<\/li>\n<li>Exclusively for personal use<\/li>\n<li>Not for resale, distribution, or commercial sale<\/li>\n<li>Subject to applicable Indian laws and regulatory approvals<\/li>\n<\/ul>\n<p>The prescribing physician remains solely responsible for dosage, therapy, and clinical decisions.<\/p>\n","protected":false},"excerpt":{"rendered":"<h2>QINLOCK (ripretinib) \u2013 GIST therapy in India<\/h2>\n<p>QINLOCK is a kinase inhibitor indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.<\/p>\n<table style=\"width: 95%;\" border=\"1\" width=\"95%\">\n<tbody>\n<tr>\n<td style=\"width: 20.6687%;\"><strong>Brand Name:<\/strong><\/td>\n<td style=\"width: 78.7234%;\">QINLOCK<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 20.6687%;\"><strong>Generic Name:<\/strong><\/td>\n<td style=\"width: 78.7234%;\">ripretinib<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 20.6687%;\"><strong>Strength:<\/strong><\/td>\n<td style=\"width: 78.7234%;\">\u2022 Tablets: 50 mg<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 20.6687%;\"><strong>Manufacturer:<\/strong><\/td>\n<td style=\"width: 78.7234%;\">Deciphera Pharmaceuticals, LLC,<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 20.6687%;\"><strong>Approved By:<\/strong><\/td>\n<td style=\"width: 78.7234%;\">EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source Details:\u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/213973s003lbl.pdf\"><strong>Patient Information<\/strong><\/a><br \/>\n<strong><em>QINLOCK must always be used under the supervision of a Registered Medical Practitioner (RMP).<\/em><\/strong><\/p>\n<h3>Access QINLOCK for gastrointestinal stromal tumor treatment on a Named Patient Import Basis<\/h3>\n<p><strong>IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to QINLOCK (ripretinib) for personal use. <\/strong>To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).<\/p>\n<p><strong>For any queries, including information regarding the cost of the pharmaceutical product in India<\/strong>, please contact the IPN Healthcare Support Team via email or at the following numbers:\u00a0<strong>Mobile\/WhatsApp:<\/strong>\u00a0Mr. Tarun: +91 9891 296 838 | \u00a0Mr. Neeraj: +91 9811 747 774.<\/p>\n<p><em><strong>Note:<\/strong>\u00a0All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.<\/em><\/p>\n","protected":false},"featured_media":8319,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":""},"product_brand":[],"product_cat":[182],"product_tag":[],"class_list":{"0":"post-8256","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-gastrointestinal","8":"first","9":"instock","10":"shipping-taxable","11":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product\/8256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media\/8319"}],"wp:attachment":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media?parent=8256"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_brand?post=8256"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_cat?post=8256"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_tag?post=8256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}